Radiosensitizer Market, Global Outlook and Forecast 2022-2028

July 2022 | 66 pages | ID: R487028FD3ACEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Radiosensitizer in Global, including the following market information:

Global Radiosensitizer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Radiosensitizer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

DNA Precursor Base Analogs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Radiosensitizer include KORTUC, Debiopharm, Kunyao Group, Shandong Xinhua Pharmaceutical Co., Ltd., Nanobiotix, Merck KGaA, Eli Lilly, Celgene and Roche Genentech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiosensitizer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Radiosensitizer Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Radiosensitizer Market Segment Percentages, by Type, 2021 (%)

• DNA Precursor Base Analogs
• Electrophilic Radiosensitizer
• Bioreductive Compounds
• Others

Global Radiosensitizer Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Radiosensitizer Market Segment Percentages, by Application, 2021 (%)

• Leukemia
• Rectal Cancer
• Head and Neck Cancer
• Breast Cancer
• Lung Cancer
• Esophageal Cancer
• Others

Global Radiosensitizer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Radiosensitizer Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Radiosensitizer revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Radiosensitizer revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• KORTUC
• Debiopharm
• Kunyao Group
• Shandong Xinhua Pharmaceutical Co., Ltd.
• Nanobiotix
• Merck KGaA
• Eli Lilly
• Celgene
• Roche Genentech
• Astellas
• EpcentRx/ SciClone
• MT3

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Radiosensitizer Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Radiosensitizer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RADIOSENSITIZER OVERALL MARKET SIZE

2.1 Global Radiosensitizer Market Size: 2021 VS 2028
2.2 Global Radiosensitizer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Radiosensitizer Players in Global Market
3.2 Top Global Radiosensitizer Companies Ranked by Revenue
3.3 Global Radiosensitizer Revenue by Companies
3.4 Top 3 and Top 5 Radiosensitizer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Radiosensitizer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radiosensitizer Players in Global Market
  3.6.1 List of Global Tier 1 Radiosensitizer Companies
  3.6.2 List of Global Tier 2 and Tier 3 Radiosensitizer Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Radiosensitizer Market Size Markets, 2021 & 2028
  4.1.2 DNA Precursor Base Analogs
  4.1.3 Electrophilic Radiosensitizer
  4.1.4 Bioreductive Compounds
  4.1.5 Others
4.2 By Type - Global Radiosensitizer Revenue & Forecasts
  4.2.1 By Type - Global Radiosensitizer Revenue, 2017-2022
  4.2.2 By Type - Global Radiosensitizer Revenue, 2023-2028
  4.2.3 By Type - Global Radiosensitizer Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Radiosensitizer Market Size, 2021 & 2028
  5.1.2 Leukemia
  5.1.3 Rectal Cancer
  5.1.4 Head and Neck Cancer
  5.1.5 Breast Cancer
  5.1.6 Lung Cancer
  5.1.7 Esophageal Cancer
  5.1.8 Others
5.2 By Application - Global Radiosensitizer Revenue & Forecasts
  5.2.1 By Application - Global Radiosensitizer Revenue, 2017-2022
  5.2.2 By Application - Global Radiosensitizer Revenue, 2023-2028
  5.2.3 By Application - Global Radiosensitizer Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Radiosensitizer Market Size, 2021 & 2028
6.2 By Region - Global Radiosensitizer Revenue & Forecasts
  6.2.1 By Region - Global Radiosensitizer Revenue, 2017-2022
  6.2.2 By Region - Global Radiosensitizer Revenue, 2023-2028
  6.2.3 By Region - Global Radiosensitizer Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Radiosensitizer Revenue, 2017-2028
  6.3.2 US Radiosensitizer Market Size, 2017-2028
  6.3.3 Canada Radiosensitizer Market Size, 2017-2028
  6.3.4 Mexico Radiosensitizer Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Radiosensitizer Revenue, 2017-2028
  6.4.2 Germany Radiosensitizer Market Size, 2017-2028
  6.4.3 France Radiosensitizer Market Size, 2017-2028
  6.4.4 U.K. Radiosensitizer Market Size, 2017-2028
  6.4.5 Italy Radiosensitizer Market Size, 2017-2028
  6.4.6 Russia Radiosensitizer Market Size, 2017-2028
  6.4.7 Nordic Countries Radiosensitizer Market Size, 2017-2028
  6.4.8 Benelux Radiosensitizer Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Radiosensitizer Revenue, 2017-2028
  6.5.2 China Radiosensitizer Market Size, 2017-2028
  6.5.3 Japan Radiosensitizer Market Size, 2017-2028
  6.5.4 South Korea Radiosensitizer Market Size, 2017-2028
  6.5.5 Southeast Asia Radiosensitizer Market Size, 2017-2028
  6.5.6 India Radiosensitizer Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Radiosensitizer Revenue, 2017-2028
  6.6.2 Brazil Radiosensitizer Market Size, 2017-2028
  6.6.3 Argentina Radiosensitizer Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Radiosensitizer Revenue, 2017-2028
  6.7.2 Turkey Radiosensitizer Market Size, 2017-2028
  6.7.3 Israel Radiosensitizer Market Size, 2017-2028
  6.7.4 Saudi Arabia Radiosensitizer Market Size, 2017-2028
  6.7.5 UAE Radiosensitizer Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 KORTUC
  7.1.1 KORTUC Corporate Summary
  7.1.2 KORTUC Business Overview
  7.1.3 KORTUC Radiosensitizer Major Product Offerings
  7.1.4 KORTUC Radiosensitizer Revenue in Global Market (2017-2022)
  7.1.5 KORTUC Key News
7.2 Debiopharm
  7.2.1 Debiopharm Corporate Summary
  7.2.2 Debiopharm Business Overview
  7.2.3 Debiopharm Radiosensitizer Major Product Offerings
  7.2.4 Debiopharm Radiosensitizer Revenue in Global Market (2017-2022)
  7.2.5 Debiopharm Key News
7.3 Kunyao Group
  7.3.1 Kunyao Group Corporate Summary
  7.3.2 Kunyao Group Business Overview
  7.3.3 Kunyao Group Radiosensitizer Major Product Offerings
  7.3.4 Kunyao Group Radiosensitizer Revenue in Global Market (2017-2022)
  7.3.5 Kunyao Group Key News
7.4 Shandong Xinhua Pharmaceutical Co., Ltd.
  7.4.1 Shandong Xinhua Pharmaceutical Co., Ltd. Corporate Summary
  7.4.2 Shandong Xinhua Pharmaceutical Co., Ltd. Business Overview
  7.4.3 Shandong Xinhua Pharmaceutical Co., Ltd. Radiosensitizer Major Product Offerings
  7.4.4 Shandong Xinhua Pharmaceutical Co., Ltd. Radiosensitizer Revenue in Global Market (2017-2022)
  7.4.5 Shandong Xinhua Pharmaceutical Co., Ltd. Key News
7.5 Nanobiotix
  7.5.1 Nanobiotix Corporate Summary
  7.5.2 Nanobiotix Business Overview
  7.5.3 Nanobiotix Radiosensitizer Major Product Offerings
  7.5.4 Nanobiotix Radiosensitizer Revenue in Global Market (2017-2022)
  7.5.5 Nanobiotix Key News
7.6 Merck KGaA
  7.6.1 Merck KGaA Corporate Summary
  7.6.2 Merck KGaA Business Overview
  7.6.3 Merck KGaA Radiosensitizer Major Product Offerings
  7.6.4 Merck KGaA Radiosensitizer Revenue in Global Market (2017-2022)
  7.6.5 Merck KGaA Key News
7.7 Eli Lilly
  7.7.1 Eli Lilly Corporate Summary
  7.7.2 Eli Lilly Business Overview
  7.7.3 Eli Lilly Radiosensitizer Major Product Offerings
  7.7.4 Eli Lilly Radiosensitizer Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly Key News
7.8 Celgene
  7.8.1 Celgene Corporate Summary
  7.8.2 Celgene Business Overview
  7.8.3 Celgene Radiosensitizer Major Product Offerings
  7.8.4 Celgene Radiosensitizer Revenue in Global Market (2017-2022)
  7.8.5 Celgene Key News
7.9 Roche Genentech
  7.9.1 Roche Genentech Corporate Summary
  7.9.2 Roche Genentech Business Overview
  7.9.3 Roche Genentech Radiosensitizer Major Product Offerings
  7.9.4 Roche Genentech Radiosensitizer Revenue in Global Market (2017-2022)
  7.9.5 Roche Genentech Key News
7.10 Astellas
  7.10.1 Astellas Corporate Summary
  7.10.2 Astellas Business Overview
  7.10.3 Astellas Radiosensitizer Major Product Offerings
  7.10.4 Astellas Radiosensitizer Revenue in Global Market (2017-2022)
  7.10.5 Astellas Key News
7.11 EpcentRx/ SciClone
  7.11.1 EpcentRx/ SciClone Corporate Summary
  7.11.2 EpcentRx/ SciClone Business Overview
  7.11.3 EpcentRx/ SciClone Radiosensitizer Major Product Offerings
  7.11.4 EpcentRx/ SciClone Radiosensitizer Revenue in Global Market (2017-2022)
  7.11.5 EpcentRx/ SciClone Key News
7.12 MT3
  7.12.1 MT3 Corporate Summary
  7.12.2 MT3 Business Overview
  7.12.3 MT3 Radiosensitizer Major Product Offerings
  7.12.4 MT3 Radiosensitizer Revenue in Global Market (2017-2022)
  7.12.5 MT3 Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Radiosensitizer Market Opportunities & Trends in Global Market
Table 2. Radiosensitizer Market Drivers in Global Market
Table 3. Radiosensitizer Market Restraints in Global Market
Table 4. Key Players of Radiosensitizer in Global Market
Table 5. Top Radiosensitizer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Radiosensitizer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Radiosensitizer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Radiosensitizer Product Type
Table 9. List of Global Tier 1 Radiosensitizer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiosensitizer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Radiosensitizer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Radiosensitizer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Radiosensitizer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Radiosensitizer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Radiosensitizer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Radiosensitizer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Radiosensitizer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Radiosensitizer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Radiosensitizer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Radiosensitizer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Radiosensitizer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Radiosensitizer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Radiosensitizer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Radiosensitizer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Radiosensitizer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Radiosensitizer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Radiosensitizer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Radiosensitizer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Radiosensitizer Revenue, (US$, Mn), 2023-2028
Table 30. KORTUC Corporate Summary
Table 31. KORTUC Radiosensitizer Product Offerings
Table 32. KORTUC Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 33. Debiopharm Corporate Summary
Table 34. Debiopharm Radiosensitizer Product Offerings
Table 35. Debiopharm Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 36. Kunyao Group Corporate Summary
Table 37. Kunyao Group Radiosensitizer Product Offerings
Table 38. Kunyao Group Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 39. Shandong Xinhua Pharmaceutical Co., Ltd. Corporate Summary
Table 40. Shandong Xinhua Pharmaceutical Co., Ltd. Radiosensitizer Product Offerings
Table 41. Shandong Xinhua Pharmaceutical Co., Ltd. Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 42. Nanobiotix Corporate Summary
Table 43. Nanobiotix Radiosensitizer Product Offerings
Table 44. Nanobiotix Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 45. Merck KGaA Corporate Summary
Table 46. Merck KGaA Radiosensitizer Product Offerings
Table 47. Merck KGaA Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly Corporate Summary
Table 49. Eli Lilly Radiosensitizer Product Offerings
Table 50. Eli Lilly Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 51. Celgene Corporate Summary
Table 52. Celgene Radiosensitizer Product Offerings
Table 53. Celgene Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 54. Roche Genentech Corporate Summary
Table 55. Roche Genentech Radiosensitizer Product Offerings
Table 56. Roche Genentech Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 57. Astellas Corporate Summary
Table 58. Astellas Radiosensitizer Product Offerings
Table 59. Astellas Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 60. EpcentRx/ SciClone Corporate Summary
Table 61. EpcentRx/ SciClone Radiosensitizer Product Offerings
Table 62. EpcentRx/ SciClone Radiosensitizer Revenue (US$, Mn), (2017-2022)
Table 63. MT3 Corporate Summary
Table 64. MT3 Radiosensitizer Product Offerings
Table 65. MT3 Radiosensitizer Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Radiosensitizer Segment by Type in 2021
Figure 2. Radiosensitizer Segment by Application in 2021
Figure 3. Global Radiosensitizer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Radiosensitizer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Radiosensitizer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Radiosensitizer Revenue in 2021
Figure 8. By Type - Global Radiosensitizer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Radiosensitizer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Radiosensitizer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Radiosensitizer Revenue Market Share, 2017-2028
Figure 12. US Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Radiosensitizer Revenue Market Share, 2017-2028
Figure 16. Germany Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 17. France Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Radiosensitizer Revenue Market Share, 2017-2028
Figure 24. China Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 28. India Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Radiosensitizer Revenue Market Share, 2017-2028
Figure 30. Brazil Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Radiosensitizer Revenue Market Share, 2017-2028
Figure 33. Turkey Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Radiosensitizer Revenue, (US$, Mn), 2017-2028
Figure 37. KORTUC Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Debiopharm Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Kunyao Group Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Shandong Xinhua Pharmaceutical Co., Ltd. Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Nanobiotix Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck KGaA Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Celgene Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Genentech Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Astellas Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. EpcentRx/ SciClone Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. MT3 Radiosensitizer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)